Physiological Response in Lung Transplant Recipients Undergoing Neurally Adjusted Ventilatory Assist
TRANS-NAVA
Physiological Response to Different Levels of Support in Lung Transplant Recipients Undergoing Neurally Adjusted Ventilatory Assist (NAVA)
1 other identifier
interventional
20
2 countries
2
Brief Summary
Primary Graft Dysfunction (PGD) respresents the leading cause of mortality in early post-operative period of Lung Tranplantation (LTx). Protective ventilatory strategy could potentially reduce the risk of PGD in these patients. Neurally Adjusted Ventilatory Assist (NAVA) is an assisted ventilation mode that could allow to adopt this strategy. Aim of the study is to assess the feasibility of NAVA in the early post-LTx phase and to describe the breathing pattern and the physiological relationship between neural respiratory drive and different levels of ventilatory assist, in the absence of pulmonary vagal afferent feedback.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2017
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 23, 2017
CompletedFirst Submitted
Initial submission to the registry
November 24, 2017
CompletedFirst Posted
Study publicly available on registry
December 8, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2019
CompletedDecember 8, 2017
December 1, 2017
1.9 years
November 24, 2017
December 7, 2017
Conditions
Outcome Measures
Primary Outcomes (5)
Evaluation of the variations of Electrical Activity of the Diaphragm in response to different levels of ventilatory assist at different degrees of lung inflation (different Positive End Expiratory Pressure values)
Electrical Activity of the Diaphragm (EAdi) (microVolt)
One hour after the recovery of spontaneous breathing
Evaluation of the variations of Neuro-Mechanical Coupling (expressed as microVolt of EAdi /cmH2O of airway pressure Ratio) in response to different levels of ventilatory assist at different degrees of lung inflation
Neuro-Mechanical Coupling (NMC) (microvolt/cmH2O)
One hour after the recovery of spontaneous breathing
Evaluation of the variations of Neuro-ventilatory Efficiency (expressed as microvolt of EAdi / mL of Tidal Volume Ratio) in response to different levels of ventilatory assist at different degree of lung inflation
Neuro-Ventilatory Efficiency (NVE) (microvolt/mL)
One hour after the recovery of spontaneous breathing
Evaluation of the changes in the patient's neural breathing pattern (expressed as mL of Tidal Volume) at different levels of ventilatory assist
Tidal Volume (mL)
One hour after the recovery of spontaneous breathing
Evaluation of the changes in the patient's neural breathing pattern (expressed as respiratory rate) at different levels of ventilatory assist
Respiratory rate (Breaths/min)
One hour after the recovery of spontaneous breathing
Secondary Outcomes (3)
Evaluation of the feasibility of Plateau Pressure during NAVA
One hour after the recovery of spontaneous breathing, with inspiratory hold manoeuvres
Ultrasound assessment of the changes of Diaphragm's Thickening Fraction at different levels of Positive End Expiratory Pressure and at different NAVA gains
One hour after the recovery of spontaneous breathing
Assesment of the total asynchrony index (double triggering + missed efforts + inspiratory trigger delay +short cycling + prolonged cycling)
One hour after the recovery of spontaneous breathing
Study Arms (1)
NAVA group
EXPERIMENTALNAVA ventilation
Interventions
Assisted Ventilation Mode, synchronized, through EAdi catheter, with patient's inspiratory effort and proportional to respiratory drive
Eligibility Criteria
You may qualify if:
- Age \> 18 y.o.
- Admission to ICU for post-operative monitoring after LTx
- Presence of spontaneous breathing activity
- Sedation titrated to a target RASS between 0 and -2
- Written informed consent obtained
You may not qualify if:
- Contraindication to nasogastric tube insertion (gastroesophageal surgery in the previous 3 months, gastroesophageal bleeding in the previous 30 days, history of esophageal varices, facial trauma)
- Increased risk of bleeding with nasogastric tube insertion, due to severe coagulation disorders and severe thrombocytopenia ( i.e., INR \> 2 and platelets count \< 70.000/mm3)
- Severe hemodynamic instability (noradenaline \> 0.3 μg/kg/min and/or use of vasopressin)
- Postoperative extracorporeal respiratory support (ECMO)
- Pre-operative reconditioning of the transplanted lungs by means of ex-vivo lung perfusion (EVLP)
- Lung retransplantation
- Failure to obtain a stable EAdi signal
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Policlinico Hospitallead
- University of Lausanne Hospitalscollaborator
Study Sites (2)
Ospedale Maggiore Policlinico
Milan, 20122, Italy
University Hospital of Lausanne
Lausanne, 10111, Switzerland
Related Publications (1)
Grasselli G, Castagna L, Abbruzzese C, Corcione N, Bottino N, Guzzardella A, Colombo SM, Carlesso E, Mauri T, Rossetti V, Palleschi A, Scaravilli V, Zanella A, Pesenti A. Pulmonary volume-feedback and ventilatory pattern after bilateral lung transplantation using neurally adjusted ventilatory assist ventilation. Br J Anaesth. 2021 Jul;127(1):143-152. doi: 10.1016/j.bja.2021.03.010. Epub 2021 Apr 21.
PMID: 33892948DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chiara Abbruzzese, MD
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- PRINCIPAL INVESTIGATOR
Luigi Castagna, MD
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- PRINCIPAL INVESTIGATOR
Nicola Bottino, MD
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- PRINCIPAL INVESTIGATOR
Alberto Zanella, MD
University of Milan
- PRINCIPAL INVESTIGATOR
Nadia Corcione, MD
Fondazione IRCCS Ca' Granda
- PRINCIPAL INVESTIGATOR
Antonio Pesenti, Prof
University of Milan
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof
Study Record Dates
First Submitted
November 24, 2017
First Posted
December 8, 2017
Study Start
November 23, 2017
Primary Completion
November 1, 2019
Study Completion
November 1, 2019
Last Updated
December 8, 2017
Record last verified: 2017-12